Sodium thiosulfate

Revision as of 21:56, 20 March 2026 by Danbot (talk | contribs) (Switch SMW query from broadtable to table format for better layout with TOC)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Administration

  • Type: Antidote
  • Dosage Forms:
  • Routes of Administration: IV
  • Common Trade Names:

Adult Dosing

Cyanide toxicity

Prophylaxis during nitroprusside infusion

  • Add 10 mg sodium thiosulfate for each 1 mg of nitroprusside

Pediatric Dosing

Cyanide toxicity

  • Pediatric: 400 mg/kg IV
  • Per micromedex: 412.5 mg/kg or 7 g/m(2) administered at a rate of 0.625 to 1.25 g/min IV

Prophylaxis during nitroprusside infusion

  • Add 10 mg sodium thiosulfate for each 1 mg of nitroprusside

Special Populations

  • Pregnancy Rating: C
  • Lactation risk: Infant risk cannot be ruled out
  • Renal dosing: not established
  • Hepatic dosing: not established

Indications

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

  • Burning sensation and muscle cramping from infusion

Pharmacology

  • Half-life: 80 min
  • Metabolism: Liver
  • Excretion: Renal

Mechanism of Action

  • Sulfur donor that promotes conversion of cyanide to thiocyanate

Comments


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Cyanide toxicity12.5 g (1.65 mL/kg of 25%)Sulfur donor for cyanide eliminationIV over 10 minAdult

See Also

References

  • Olson, K. Poisoning and Drug Overdose, 1999.